CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 13 enrolled
Drug / intervention
Salvinorin Adrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03418714
NCT03418714Phase 2Completed
CompareCT.gov

Effects of Salvinorin A on Brain Function

Johns Hopkins University·interventional·Posted Feb 1, 2018·Updated Mar 4, 2021

In Brief

A Phase 2 clinical trial evaluating Salvinorin A for Drug Effect. Completed, enrolled 13 participants across 1 site.

Detailed Summary

This study will investigate the effects of salvinorin A on human brain activity and connectivity using functional magnetic resonance imaging (fMRI) methods. An inhalation route of administration will be used as it is the most common route for contemporary use of Salvia divinorum, a plant containing salvinorin A.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDrug Effect
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedFeb 1, 2018
Enrollment StartDec 14, 2017
Primary CompletionMar 2, 2020
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 8.4 years ago

Interventions

Salvinorin Adrug

Salvinorin A, blinded doses